Treatment Strategy for Multiple Myeloma to Improve Immunological Environment and Maintain MRD Negativity

Treatment Strategy for Multiple Myeloma to Improve Immunological Environment and Maintain MRD Negativity

Improving the immunological environment and eradicating minimal residual disease (MRD) are the two main treatment goals for long-term survival in patients with multiple myeloma (MM). Immunomodulatory drugs (IMiDs), monoclonal antibody drugs (MoAbs), and autologous grafts for autologous stem cell tra...

Full description

Bibliographic Details
Main Authors: Kazuhito Suzuki, Kaichi Nishiwaki, Shingo Yano
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
multiple myeloma
immune environment
minimal residual disease
proteasome inhibitor
immunomodulatory drug
monoclonal antibody
Online Access:https://www.mdpi.com/2072-6694/13/19/4867

Internet

https://www.mdpi.com/2072-6694/13/19/4867

Similar Items